Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Proceedings of the University of Pennsylvania 11th annual conference on statistical issues in clinical trials: Estimands, missing data and sensitivity analysis.

Ellenberg SS, Ellenberg JH.

Clin Trials. 2019 Aug;16(4):337-338. doi: 10.1177/1740774519853569. Epub 2019 Jun 27. No abstract available.

PMID:
31244345
2.

Proceedings of the University of Pennsylvania 10th annual conference on statistical issues in clinical trials: Current issues regarding Data and Safety Monitoring Committees in clinical trials.

Ellenberg SS, Ellenberg JH.

Clin Trials. 2018 Aug;15(4):319-320. doi: 10.1177/1740774518781817. Epub 2018 Jun 22. No abstract available.

PMID:
29932002
3.

Proceedings of the University of Pennsylvania ninth annual conference on statistical issues in clinical trials: Where are we with adaptive clinical trial designs?

Ellenberg SS, Ellenberg JH.

Clin Trials. 2017 Oct;14(5):415-416. doi: 10.1177/1740774517723606. Epub 2017 Aug 4. No abstract available.

PMID:
28776406
4.

Proceedings of the University of Pennsylvania eighth annual conference on statistical issues in clinical trials: Statistical issues in pragmatic clinical trials.

Ellenberg SS, Ellenberg JH.

Clin Trials. 2016 Oct;13(5):469-70. doi: 10.1177/1740774516655347. No abstract available.

PMID:
27630247
5.

Low Vision Rehabilitation for Adult African Americans in Two Settings.

Draper EM, Feng R, Appel SD, Graboyes M, Engle E, Ciner EB, Ellenberg JH, Stambolian D.

Optom Vis Sci. 2016 Jul;93(7):673-82. doi: 10.1097/OPX.0000000000000870.

PMID:
27092929
6.

Proceedings of the University of Pennsylvania 7th annual conference on statistical issues in clinical trials: The use of biomarkers and surrogate endpoints in clinical trials.

Ellenberg SS, Ellenberg JH.

Clin Trials. 2015 Aug;12(4):297-8. doi: 10.1177/1740774515590088. No abstract available.

PMID:
26178572
7.

Prematurity and respiratory outcomes program (PROP): study protocol of a prospective multicenter study of respiratory outcomes of preterm infants in the United States.

Pryhuber GS, Maitre NL, Ballard RA, Cifelli D, Davis SD, Ellenberg JH, Greenberg JM, Kemp J, Mariani TJ, Panitch H, Ren C, Shaw P, Taussig LM, Hamvas A; Prematurity and Respiratory Outcomes Program Investigators.

BMC Pediatr. 2015 Apr 10;15:37. doi: 10.1186/s12887-015-0346-3.

8.

Respiratory consequences of prematurity: evolution of a diagnosis and development of a comprehensive approach.

Maitre NL, Ballard RA, Ellenberg JH, Davis SD, Greenberg JM, Hamvas A, Pryhuber GS; Prematurity and Respiratory Outcomes Program.

J Perinatol. 2015 May;35(5):313-321. doi: 10.1038/jp.2015.19. Epub 2015 Mar 26. Review.

9.

Shorter time to target temperature is associated with poor neurologic outcome in post-arrest patients treated with targeted temperature management.

Perman SM, Ellenberg JH, Grossestreuer AV, Gaieski DF, Leary M, Abella BS, Carr BG.

Resuscitation. 2015 Mar;88:114-9. doi: 10.1016/j.resuscitation.2014.10.018. Epub 2014 Oct 30.

10.

Immune markers predictive of neuropsychiatric symptoms in HIV-infected youth.

McGuire JL, Kempen JH, Localio R, Ellenberg JH, Douglas SD.

Clin Vaccine Immunol. 2015 Jan;22(1):27-36. doi: 10.1128/CVI.00463-14. Epub 2014 Oct 29.

11.

Proceedings of the University of Pennsylvania 6th annual conference on statistical issues in clinical trials: Dynamic treatment regimes.

Ellenberg JH, Ellenberg SS.

Clin Trials. 2014 Aug;11(4):391-392. Epub 2014 Jul 22. No abstract available.

12.

Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosis.

Waldman AT, Hiremath G, Avery RA, Conger A, Pineles SL, Loguidice MJ, Talman LS, Galetta KM, Shumski MJ, Wilson J, Ford E, Lavery AM, Conger D, Greenberg BM, Ellenberg JH, Frohman EM, Balcer LJ, Calabresi PA.

Mult Scler Relat Disord. 2013 May 1;3(3):326-334.

13.

A pharmacogenetic versus a clinical algorithm for warfarin dosing.

Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, Rosenberg YD, Eby CS, Madigan RA, McBane RB, Abdel-Rahman SZ, Stevens SM, Yale S, Mohler ER 3rd, Fang MC, Shah V, Horenstein RB, Limdi NA, Muldowney JA 3rd, Gujral J, Delafontaine P, Desnick RJ, Ortel TL, Billett HH, Pendleton RC, Geller NL, Halperin JL, Goldhaber SZ, Caldwell MD, Califf RM, Ellenberg JH; COAG Investigators.

N Engl J Med. 2013 Dec 12;369(24):2283-93. doi: 10.1056/NEJMoa1310669. Epub 2013 Nov 19.

14.
15.

Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial.

Kimmel SE, French B, Anderson JL, Gage BF, Johnson JA, Rosenberg YD, Geller NL, Kasner SE, Eby CS, Joo J, Caldwell MD, Goldhaber SZ, Hart RG, Cifelli D, Madigan R, Brensinger CM, Goldberg S, Califf RM, Ellenberg JH.

Am Heart J. 2013 Sep;166(3):435-41. doi: 10.1016/j.ahj.2013.04.009. Epub 2013 Jul 12. Erratum in: Am Heart J. 2014 Feb;167(2):281. Dosage error in article text.

16.

Association between efavirenz-based compared with nevirapine-based antiretroviral regimens and virological failure in HIV-infected children.

Lowenthal ED, Ellenberg JH, Machine E, Sagdeo A, Boiditswe S, Steenhoff AP, Rutstein R, Anabwani G, Gross R.

JAMA. 2013 May 1;309(17):1803-9. doi: 10.1001/jama.2013.3710.

17.

Factors associated with a willingness to accept rapid HIV testing in an urban emergency department.

Bamford L, Ellenberg JH, Hines J, Vinnard C, Jasani A, Gross R.

AIDS Behav. 2014 Feb;18(2):250-3. doi: 10.1007/s10461-013-0452-x.

18.
19.

The association of cerebral palsy with birth asphyxia: a definitional quagmire.

Ellenberg JH, Nelson KB.

Dev Med Child Neurol. 2013 Mar;55(3):210-6. doi: 10.1111/dmcn.12016. Epub 2012 Nov 2. Review.

20.

Commentary on 'How the debate about comparative effectiveness research (CER) should impact the future of clinical trials' by Michael S. Lauer.

Ellenberg JH.

Stat Med. 2012 Nov 10;31(25):3054-6; discussion 3066-7. doi: 10.1002/sim.5399. No abstract available.

PMID:
23055181
21.

Infusion of statistical science in comparative effectiveness research.

Morton SC, Ellenberg JH.

Clin Trials. 2012 Feb;9(1):6-12. doi: 10.1177/1740774511433044.

PMID:
22334463
22.

Proceedings of the University of Pennsylvania annual conference on statistical issues in clinical trials: statistical issues in comparative effectiveness research.

Ellenberg JH, Ellenberg SS.

Clin Trials. 2012 Feb;9(1):5. doi: 10.1177/1740774511433045. No abstract available.

PMID:
22334462
23.

Concurrent validity and reliability of retrospective scoring of the Pediatric National Institutes of Health Stroke Scale.

Beslow LA, Kasner SE, Smith SE, Mullen MT, Kirschen MP, Bastian RA, Dowling MM, Lo W, Jordan LC, Bernard TJ, Friedman N, DeVeber G, Kirton A, Abraham L, Licht DJ, Jawad AF, Ellenberg JH, Lautenbach E, Ichord RN.

Stroke. 2012 Feb;43(2):341-5. doi: 10.1161/STROKEAHA.111.633305. Epub 2011 Nov 10.

24.

Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trial.

French B, Joo J, Geller NL, Kimmel SE, Rosenberg Y, Anderson JL, Gage BF, Johnson JA, Ellenberg JH; COAG (Clarification of Optimal Anticoagulation through Genetics) Investigators.

Trials. 2010 Nov 17;11:108. doi: 10.1186/1745-6215-11-108.

25.

Exogenous estrogen does not attenuate the association between rofecoxib and myocardial infarction in perimenopausal women.

Wade KC, Ellenberg JH, Grosser T, Brensinger CM, Kimmel SE, Hennessy S.

J Cardiovasc Pharmacol. 2011 Feb;57(2):194-200. doi: 10.1097/FJC.0b013e31820350d3.

26.

Proceedings of the University of Pennsylvania annual conference on statistical issues in clinical trials: statistical issues in developing targeted therapies. Forward.

Ellenberg JH, Ellenberg SS.

Clin Trials. 2010 Oct;7(5):513-5. doi: 10.1177/1740774510380504. No abstract available.

PMID:
20861200
27.

Prospective alpha allocation in the Clarification of Optimal Anticoagulation through Genetics (COAG) trial.

Joo J, Geller NL, French B, Kimmel SE, Rosenberg Y, Ellenberg JH.

Clin Trials. 2010 Oct;7(5):597-604. doi: 10.1177/1740774510381285. Epub 2010 Aug 6.

28.

The National Children's Study (NCS): establishment and protection of the inferential base.

Ellenberg JH.

Stat Med. 2010 Jun 15;29(13):1360-7. doi: 10.1002/sim.3635.

30.

Proceedings of the University of Pennsylvania annual conference on statistical issues in clinical trials: early, translational and proof of concept studies: the 'go/no go' decisions.

Ellenberg JH, Mick R, Ellenberg SS.

Stat Med. 2010 May 10;29(10):1059-60. doi: 10.1002/sim.3688. No abstract available.

PMID:
20419757
31.

Variation in receipt of opioids by pediatric oncology patients who died in children's hospitals.

Orsey AD, Belasco JB, Ellenberg JH, Schmitz KH, Feudtner C.

Pediatr Blood Cancer. 2009 Jul;52(7):761-6. doi: 10.1002/pbc.21824.

PMID:
18989880
32.

Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis.

Lewis JD, Chuai S, Nessel L, Lichtenstein GR, Aberra FN, Ellenberg JH.

Inflamm Bowel Dis. 2008 Dec;14(12):1660-6. doi: 10.1002/ibd.20520.

33.

Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.

Lewis JD, Lichtenstein GR, Deren JJ, Sands BE, Hanauer SB, Katz JA, Lashner B, Present DH, Chuai S, Ellenberg JH, Nessel L, Wu GD; Rosiglitazone for Ulcerative Colitis Study Group.

Gastroenterology. 2008 Mar;134(3):688-95. doi: 10.1053/j.gastro.2007.12.012. Epub 2007 Dec 7.

34.

Associations among body composition, androgen levels, and human immunodeficiency virus status in adolescents.

Moscicki AB, Ellenberg JH, Murphy DA, Jiahong X.

J Adolesc Health. 2006 Aug;39(2):164-73.

PMID:
16857527
35.

A unified web-based query and notification system (QNS) for subject management, adverse events, regulatory, and IRB components of clinical trials.

Mitchell R, Shah M, Ahmad S, Rogers AS, Ellenberg JH; Adolescent Medicine Trials Network for HIV/AIDS Interventions.

Clin Trials. 2005;2(1):61-71.

PMID:
16279580
36.

Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents.

Moscicki AB, Ellenberg JH, Crowley-Nowick P, Darragh TM, Xu J, Fahrat S.

J Infect Dis. 2004 Oct 15;190(8):1413-21. Epub 2004 Sep 13.

PMID:
15378433
37.

Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.

Moscicki AB, Ellenberg JH, Farhat S, Xu J.

J Infect Dis. 2004 Jul 1;190(1):37-45. Epub 2004 Jun 8.

PMID:
15195241
38.

CD8+CD38+ T cells but not HIV type 1 RNA viral load predict CD4+ T cell loss in a predominantly minority female HIV+ adolescent population.

Wilson CM, Ellenberg JH, Douglas SD, Moscicki AB, Holland CA; Reach Project Of The Adolescent Medicine HIV/AIDS Research Network.

AIDS Res Hum Retroviruses. 2004 Mar;20(3):263-9. Erratum in: AIDS Res Hum Retroviruses. 2004 May;20(5):575.

PMID:
15117448
39.

Recruitment and retention of adolescent participants in HIV research: findings from the REACH (Reaching for Excellence in Adolescent Care and Health) Project.

Stanford PD, Monte DA, Briggs FM, Flynn PM, Tanney M, Ellenberg JH, Clingan KL, Rogers AS; Reaching for Excellence in Adolescent Care and Health Project.

J Adolesc Health. 2003 Mar;32(3):192-203.

PMID:
12606113
40.

The risk of mortality or cerebral palsy in twins: a collaborative population-based study.

Scher AI, Petterson B, Blair E, Ellenberg JH, Grether JK, Haan E, Reddihough DS, Yeargin-Allsopp M, Nelson KB.

Pediatr Res. 2002 Nov;52(5):671-81.

PMID:
12409512
41.

Serologic response to hepatitis B vaccine in HIV infected and high-risk HIV uninfected adolescents in the REACH cohort. Reaching for Excellence in Adolescent Care and Health.

Wilson CM, Ellenberg JH, Sawyer MK, Belzer M, Crowley-Nowick PA, Puga A, Futterman DC, Peralta L; Adolescent Medicine HIV/AIDS Research Network.

J Adolesc Health. 2001 Sep;29(3 Suppl):123-9.

PMID:
11530313
42.

Performance of antigens used in detecting delayed-type hypersensitivity in adolescents infected with the human immunodeficiency virus.

Rogers AS, Ellenberg JH, Douglas SD, Henry-Reid L, Peralta L, Wilson CM; Adolescent Medicine HIV/AIDS Research Network.

Clin Diagn Lab Immunol. 2001 Mar;8(2):273-8.

43.

The closeout process for a clinical trial terminated early for lagging enrollment and inadequate follow-up.

Muth K, Yu E, Alston B, Ellenberg JH.

Control Clin Trials. 2001 Feb;22(1):49-55.

PMID:
11165423
44.

The prevalence of anergy in human immunodeficiency virus-infected adolescents and the association of delayed-type hypersensitivity with subject characteristics.

Smith Rogers A, Ellenberg JH, Douglas SD, Henry-Reid L, Peralta L, Wilson CM.

J Adolesc Health. 2000 Dec;27(6):384-90.

PMID:
11090740
45.

Relationship of CD4+ T cell counts and HIV type 1 viral loads in untreated, infected adolescents. Adolescent Medicine HIV/AIDS Research Network.

Holland CA, Ellenberg JH, Wilson CM, Douglas SD, Futterman DC, Kingsley LA, Moscicki AB.

AIDS Res Hum Retroviruses. 2000 Jul 1;16(10):959-63.

PMID:
10890357
46.

Cytokine profile in genital tract secretions from female adolescents: impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens.

Crowley-Nowick PA, Ellenberg JH, Vermund SH, Douglas SD, Holland CA, Moscicki AB.

J Infect Dis. 2000 Mar;181(3):939-45.

PMID:
10720516
47.

Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus.

Moscicki AB, Ellenberg JH, Vermund SH, Holland CA, Darragh T, Crowley-Nowick PA, Levin L, Wilson CM.

Arch Pediatr Adolesc Med. 2000 Feb;154(2):127-34.

PMID:
10665598
49.

Febrile seizures: is the EEG a useful predictor of recurrences?

Kuturec M, Emoto SE, Sofijanov N, Dukovski M, Duma F, Ellenberg JH, Hirtz DG, Nelson KB.

Clin Pediatr (Phila). 1997 Jan;36(1):31-6.

PMID:
9007345
50.

Posttraumatic Amnesia as a predictor of outcome after severe closed head injury. Prospective assessment.

Ellenberg JH, Levin HS, Saydjari C.

Arch Neurol. 1996 Aug;53(8):782-91.

PMID:
8759985

Supplemental Content

Loading ...
Support Center